ArticleFrontiers in oncology2023

Early post-bevacizumab change in rCBV from DSC-MRI identifies pseudoresponse in recurrent glioblastoma: Results from ACRIN 6677/RTOG 0625.

Jerrold L Boxerman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.